by Fred Fuld III
We recently published an article on tax selling stocks, which listed several stocks that had dropped significantly this year. Tax selling stocks are ones which are overly depressed in price due to stockholders wanting to take advantage of their capital losses before year-end. Often, these stocks bounce in January when the selling pressure is off.
Some stock traders like to look for additional criteria when they choose which tax selling stocks to buy, and one that is popular is below-cash stocks. These are stocks that if you divided the company’s total cash by the number of outstanding shares, that cash value exceeds the current stock price.
In other words, the stock is trading below the amount of cash available per share. With that much cash, it is hard for a company to go out of business within a month. In addition, it sometimes makes these stocks takeover opportunities.
Of course, there is no guarantee that these stocks will bounce in January. They could continue to drift downward or stay around the same price for a long time.
Here is a list of non-biotech stocks that are down over 50% year-to-date and are selling below cash per share. Also, all of these are selling below $7 per share. In addition, many of them have had increasing revenues over the past few years.
| AFIB |
| AQB |
| ASTC |
| BTBT |
| CMMB |
| CNTX |
| DSS |
| EKSO |
| FKWL |
| FNHC |
| FVE |
| LCI |
| MAPS |
| MYPS |
| NUWE |
| ONVO |
| ROOT |
| SLDB |
| VIVE |
Please keep in mind that these are extremely low cap stocks and are therefore extremely speculative.
Disclosure: At the time the article was written, author owned AFIB AQB ASTC BTBT CMMB CNTX DSS EKSO FKWL FNHC FVE LCI MAPS MYPS NUWE ONVO ROOT
